Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. A. Alferov
Clinical Analysis of Serum Interleukin-16 and Vascular Endothelial Growth Factor Levels Depending on Morphological Characteristics of the Tumors and Long-Term Treatment Outcomes in Patients With Bone Neoplasms
Almanac of Clinical Medicine
Soluble Forms of the Immune Check-Point Receptor PD-1 and Its Ligand PD-L1 in Blood Serum of Patients With Renal Cell Carcinoma: Clinical and Pathologic Correlations
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
Related publications
Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome
Archives of Rheumatology
Rheumatology
Serum Vascular Endothelial Growth Factor Load and Interleukin-6 in Cancer Patients – Reply
British Journal of Cancer
Cancer Research
Oncology
Predictive Factors and Long-Term Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment of Retinal Angiomatous Proliferation
Clinical Ophthalmology
Ophthalmology
Vascular Endothelial Growth Factor-A Levels in Term Neonates
Journal of Child Science
Child Health
Surgery
Pediatrics
Perinatology
Serum Levels of Vascular Endothelial Growth Factor and Hemoglobin Dielectric Properties in Patients With Systemic Lupus Erythematosus
Journal of Medical Sciences
Medicine
Serum Levels of Vascular Endothelial Growth Factor and Transforming Growth Factor-.Beta.1 in Patients With Atrial Fibrillation Undergoing Defibrillation Therapy.
Japanese Heart Journal
Serum Levels of Vascular Endothelial Growth Factor in Patients With Acute Myocardial Infarction Undergoing Reperfusion Therapy
Clinical Science
Medicine
Serum Levels of Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (bFGF) in Children With Brain Tumours
Advances in Clinical and Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology